Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Cyclophosphamide 641 Bevacizumab 552 Paclitaxel 535 Carboplatin 533 Cisplatin 480 pembrolizumab 457 Gemcitabine 422 Docetaxel 416 Rituximab 386 Radiotherapy 373 Dexamethasone 352 Doxorubicin 330 Nivolumab 309 Fluorouracil 286 Capecitabine 260 Etoposide 245 Prednisone 244 Oxaliplatin 242 Erlotinib Hydrochloride 242 Cytarabine 233 Lenalidomide 232 Trastuzumab 226 Pemetrexed 220 Vincristine 212 fludarabine phosphate 208 Leucovorin 208 Cetuximab 208 Filgrastim 204 Bortezomib 193 Methotrexate 183

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × MK-4166 × Clear all

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡